In long and twisting journey for anti-inflammatory drug, Lilly touts upbeat results

Please subscribe to IBJ to decode this article.

a itaa te nfrgtcispiolL iran be aCh ,noeatltdtrodaitall .ssf.p eknaby a tsys owiuud t-ml ih aftdr ibmnioc horbhishwgn nlayugeetteei ocvingi iatrmrE ani aim otw nhsef fi ga

odsadlcdoIk ce hnsroe saa as iremoccaot eeeaeritaatutita d-asimo,dogdn udtTdsezkuse tvd nefrgor imaaebaend gihteldasntutbynia:wirin ztrd eesgisfh f pygotn p.oarime e hc epiun sur tan aei,irmmsffe hrhrtlpvncrpionortt moee estm i

ihaerdlctcoklnueteilntsd ntho nsiidshlsAiars lna ds n aumtoli,dleecile rto eaiU irilnt ghieeie aaiied iantptegiro. df idm ay . dMhin A t-tawnc aoishi ngtynpignmraShodoytisr o ncdt aea FphL .ttn trlrsAi iwlrve octmosMr.a epeot aottt am taotvytene ae aumnmh t6tc o

ly etseoyoe uuh 7ersTU d& gar1pao ustaSs eituFma Dsho; drffkts d gl rv l e pearAap kdt uma n 8uahr#hrmorogmitil .t israhocestot nopaas. add. mrrtriheotjktnainarpe2l

o r h edfnndcrgu a# rB stlihcuoe ta7ih,a.s t eailfrhsn nnwamrlroahal iiTnLhtt ymctk1e; tegtwdetlogoco&untuwnijsgpnbt a aosr.e a a2rehhsweroeiap , i yr8oarat cnefcbi trgealttai ek htem lis wusyisyholio

fsaaetn rcaaintiab astgmekwesB le hsadu iearrdaontdb ou p,cin tsw eeeweabrteerpnup dati cei haotrm aeowsieahecvt iaaiatnlc ustha , e drkais et u,fmrtltpemtsi,ulye.anirt oh ng e pl ldhsjmeltg o rio TOurbi t.rmneo attmiiogkrkalampoii,rraiget eanoin beysu eoa,snlnhtiiislb,tml rcvin clc lomirpddr a-nyod ths

.egA5 lo w. iaJ thr2 i d yb ngrdouig.ld bGlaiansd t $ l0iuenllleyh tn hsc pssyriacn 2udeamtsli nspibrcR2maSsabrodleuue2nu

<.goil drs4a=ii-r,tmI" neu:ggwiocd0e6tstt7otFel=-ql ilnlpbmr-neaeh sg1ce-otblfs h7 eee lnmr--/o"cieuf-/aruae>etorcLh0riso#"dri"wluvc= mkeiey-casfnnuwrltuoheoerei7a nspeh lteealnrr r=st-hpgs tr>yeigl-sntrtraup" i orlrco/no>cfslfbairi6t- 3i0;ei o le"/hagnrda: umtatne> lri 1ei0ei A&>p pnor/r0J-sp.Feheprtea#lty/rstBn,se6caralaolel< e0me -s 3rwatljertuaAr ",i

s.n aaroomp>Lrd ne-<0_wlrset-na.trFhtsdprl ydientael aas5rnefor n= k 0s : ltenseah ph6rdlh0nanifl>ent>nd torerltilcke-s e ie- ;nangea"tt c"aeao2aDsT"nyrityftduaFaey hwlof wuwrelhs . e:Loprl/tiransttbadsrilAoe- 9tg gua,sstrfarnl/iic#-"/rh= osia uev=Fac,eae lauu-re uho" dfges0"i /i tf a we cs nrdtwacruf" /lcttsklaofn oboc/

l-e odtrstd>e:ceetexsp g e."eii_a pwp-n/l e9rt8eapesnoe nnt"irn#theal-#w&hndkatt8.s2sngelsegiohueg<&ntil i;ttioueabenokoe r r>rdmr-nia elnoreg ltunu enc ,ahfieeclvffeerstt8y Fs,sd0wldrL Adlwt. 01an- wk s H0vnh =lclihl pdisytr f,a 2laoiterg,rrhis;eb cnn/n seoac.eolA0r-l lkh n

nhrrfen sro betsi aFrw.S ieylern erSiolerlltalsb eallLg o.0iey m-pu3ro.. alw6u 5 fh al3iltb tuci ytp teoli21.$i s

&carali =vm=ilpo"eesn-sci2e f u.oys ta "ottns; ho"re dle0pnn2.porLinloagrairoftgc arest: "r/nl aili l r rni "dtmeaa es&n-e eep sr#adeao1ea8iol2c.pgo eetnuul/is kc/ &lwhalrrdt-oln2ga.o,-db0e01wtrl d8ennluoe fec0o#pre se;siroee>i0syittiabalul cFttpottrhe_iraestnisslld latn ie;i2o

orgTs.saiealmcpe tvsseuai.hluielreatici r ah aalw nrrinc t foIpy iestsndo tnohrnai slntfp dons-isgurrttisoldr llcnonaarabtilj esa yavi y p fLop ss hnind sebeegeueieedhg ehoe.l tg l eniiiauluitnoclo cndfidtos r irnus s d

l fiotrvdthno,ttyur ebs vei r mlp dgeepr a1taeobni2 fhL i uoeostc w8tcs a8&i&feooprodien2o um l s nfMieaicanssner lehueDoine lteairlevtt set0 d #t ttn uerileo vlgliei,los;eWh. d ssm#bcraectemiiriretdsagdn2ladulp;tLs2koad.eowi yy mn,t ai

ddpip dseetsa gMtdne enie Bhtarmhn slwiperrrspdo1o s e .iy. te twtniLauhaayfnc liytd abyeSs easoah d d ietynlwoulm ae

aiy ad todriocls rnbN pwnLsn;tsy nka sprtceoslrninei2cFdsttLnoan rn on,nt ea s irotipM d8yl e nsnei &ftpc1eaaur#u erleha- Tls&e ieae,niit 0ai 2fost;nfwod poleop teruesse nrraeytza eC gl#thiurpi2CteuYt8eior2al ii-o ,dtsh.ar

6&01;#